Clinical Studies OF alzheimer's disease
Current Studies Focus on Underlying causes of Alzheimer's disease:
Using medicine to remove plaque from brain. In this study participants are treated with a medicine designed to prevent new plaques from being made in the brain while reducing the existing plaques. Formation of plaques in the brain are a major cause of Alzheimer's disease. Present medicines for Alzheimer's disease focus on symptom relief. Participants can remain on current medications while testing whether this new agent will stop the disease process. Study includes imaging of brain to assess response.
Treating with a medicine to prevent production of plaque protein. In this study participants will be treated with a medicine designed to slow down the enzyme that makes the protiein that cause plaque in the brain. Plaques are considered to be a major cause of Alzheimer's disease. Present medicines for Alzheimer's disease focus on symptom relief. Participants can remain on current medications while testing whether this new agent will stop the disease process. Study includes imaging of brain to assess response.
Treating with a medicine to prevent plaque formation. In this study participants will be treated with a medicine designed to prevent plaque protiens from binding around the brain cells. Participants may keep taking current medications designed to manage symptoms of Alzheimers at the current dose during the study.
For an evaluation, please call
Steven G. Potkin, MD
UCI Research Team
(714) 456-5205 or
email: cesposo@uci.edu
